Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.

Kim JH, Cheon JH, Hong SS, Eun CS, Byeon JS, Hong SY, Kim BY, Kwon SH, Kim SW, Han DS, Yang SK, Kim WH.

J Clin Gastroenterol. 2010 Nov-Dec;44(10):e242-8. doi: 10.1097/MCG.0b013e3181d6baf5.

PMID:
20308917
[PubMed - indexed for MEDLINE]
2.

Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.

Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW.

Clin Gastroenterol Hepatol. 2006 Jan;4(1):44-9.

PMID:
16431304
[PubMed - indexed for MEDLINE]
3.

Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.

Takatsu N, Matsui T, Murakami Y, Ishihara H, Hisabe T, Nagahama T, Maki S, Beppu T, Takaki Y, Hirai F, Yao K.

J Gastroenterol Hepatol. 2009 Jul;24(7):1258-64. doi: 10.1111/j.1440-1746.2009.05917.x.

PMID:
19682195
[PubMed - indexed for MEDLINE]
4.

Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs.

Jung YS, Cheon JH, Park JJ, Moon CM, Kim ES, Lee JH, Kim SW, Kim JH, Hong SP, Kim TI, Kim WH.

J Hum Genet. 2010 Feb;55(2):121-3. doi: 10.1038/jhg.2009.125. Epub 2009 Dec 4.

PMID:
19960028
[PubMed - indexed for MEDLINE]
5.

Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.

Cheon JH, Kim JH, Kim BY, Kim SW, Hong SY, Eun CS, Hong SS, Byeon JS, Kim TI, Han DS, Yang SK, Lee KR, Kim WH.

Hepatogastroenterology. 2009 Mar-Apr;56(90):421-3.

PMID:
19579612
[PubMed - indexed for MEDLINE]
6.

Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?

Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H.

Ther Drug Monit. 2012 Dec;34(6):695-701. doi: 10.1097/FTD.0b013e3182731925.

PMID:
23149442
[PubMed - indexed for MEDLINE]
7.

Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.

Uchiyama K, Nakamura M, Kubota T, Yamane T, Fujise K, Tajiri H.

J Gastroenterol. 2009;44(3):197-203. doi: 10.1007/s00535-008-2307-1. Epub 2009 Feb 13.

PMID:
19214663
[PubMed - indexed for MEDLINE]
8.

Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.

Ban H, Andoh A, Tanaka A, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y.

Intern Med. 2008;47(19):1645-8. Epub 2008 Oct 1.

PMID:
18827410
[PubMed - indexed for MEDLINE]
Free Article
9.

Pharmacogenetics of thiopurine therapy in paediatric IBD patients.

De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW.

Aliment Pharmacol Ther. 2006 Apr 15;23(8):1137-41.

PMID:
16611274
[PubMed - indexed for MEDLINE]
Free Article
10.

Review article: thiopurines in inflammatory bowel disease.

Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):715-29. Review.

PMID:
16918876
[PubMed - indexed for MEDLINE]
Free Article
11.

Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.

Winter JW, Gaffney D, Shapiro D, Spooner RJ, Marinaki AM, Sanderson JD, Mills PR.

Aliment Pharmacol Ther. 2007 May 1;25(9):1069-77.

PMID:
17439508
[PubMed - indexed for MEDLINE]
Free Article
12.

The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.

Gao X, Zhang FB, Ding L, Liu H, Wang XD, Chen BL, Bi HC, Xiao YL, Zhao LZ, Chen MH, Huang M, Hu PJ.

Eur J Gastroenterol Hepatol. 2012 Aug;24(8):958-64. doi: 10.1097/MEG.0b013e3283545ae3.

PMID:
22664938
[PubMed - indexed for MEDLINE]
13.

No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.

Lindqvist M, Hindorf U, Almer S, Söderkvist P, Ström M, Hjortswang H, Peterson C.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1033-7.

PMID:
17065060
[PubMed - indexed for MEDLINE]
14.

Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.

Hindorf U, Lindqvist M, Peterson C, Söderkvist P, Ström M, Hjortswang H, Pousette A, Almer S.

Gut. 2006 Oct;55(10):1423-31. Epub 2006 Mar 16.

PMID:
16543290
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Thiopurine therapy in inflammatory bowel disease.

Ha C, Dassopoulos T.

Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59. Review.

PMID:
20932143
[PubMed - indexed for MEDLINE]
16.

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.

Ansari A, Elliott T, Baburajan B, Mayhead P, O'Donohue J, Chocair P, Sanderson J, Duley J.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):734-41.

PMID:
19145729
[PubMed - indexed for MEDLINE]
17.

[Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].

Alvarez Beltran M, Infante Pina D, Tormo Carnicé R, Segarra Cantón O, Redecillas Ferreiro S.

An Pediatr (Barc). 2009 Feb;70(2):126-31. doi: 10.1016/j.anpedi.2008.10.010. Epub 2009 Feb 3. Spanish.

PMID:
19217567
[PubMed - indexed for MEDLINE]
Free Article
18.

Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.

Palmieri O, Latiano A, Bossa F, Vecchi M, D'Incà R, Guagnozzi D, Tonelli F, Cucchiara S, Valvano MR, Latiano T, Andriulli A, Annese V.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):737-45. Erratum in: Aliment Pharmacol Ther. 2007 Sep 15;26(6):968.

PMID:
17697207
[PubMed - indexed for MEDLINE]
Free Article
19.

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.

Zabala-Fernández W, Barreiro-de Acosta M, Echarri A, Carpio D, Lorenzo A, Castro J, Martínez-Ares D, Pereira S, Martin-Granizo I, Corton M, Carracedo A, Barros F.

J Gastrointestin Liver Dis. 2011 Sep;20(3):247-53.

PMID:
21961091
[PubMed - indexed for MEDLINE]
Free Article
20.

[Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].

Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.

Med Clin (Barc). 2003 Jun 7;121(1):1-5. Spanish.

PMID:
12812701
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk